Griffiths Richard Ian
Transaction: 07/06/2026
BUY
Change
+865,112
Price
$10.53
Filing
07/07/2026
Type
BUY
Silence Therapeutics plc
SLN • Biotechnology
$19.62
▲ +0.01 (+0.05%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$921.82M
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Manageable debt level · 0Healthy liquidity · 8.72Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 12, 2026, 12:16 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$19.62
Change0.05%
Shares Out47.24M
Market Cap$921.82M
Enterprise Value$849.66M
52W Range4.19 - 17.58
Beta1.35
P/E-15.38
P/S1,500.63
P/B-23.96
P/FCF-21.78
EV/Sales1,383.15
Price$19.62
Change0.05%
Shares Out47.24M
Market Cap$921.82M
Enterprise Value$849.66M
52W Range4.19 - 17.58
Beta1.35
P/E-15.38
P/S1,500.63
P/B-23.96
P/FCF-21.78
EV/Sales1,383.15
EV/EBITDA-17.68
EV/FCF-20.08
Earnings Yield-6.50%
FCF Yield-4.59%
Dividend Yield0.00%
Gross Margin61.54%
Oper. Margin-160.56%
Profit Margin-158.52%
Debt/Eq0.00
Current Ratio8.72
Quick Ratio8.72
Target$57.00
Target Upside190.52%
Target Median$55.00
Target Range49.00 - 67.00
Volume3.28M
Avg Volume422.88K
EPS Surprise0.01
Investment DNA
How strong this company looks for long-term investors
35
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
42/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 8.72Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-12
Low
$49.00
Mean
$57.00
Median
$55.00
High
$67.00
Insider Transactions
Recent executive and insider activity
Griffiths Richard Ian
Transaction: 07/02/2026
BUY
Change
+50,082
Price
$10.47
Filing
07/07/2026
Type
BUY
Griffiths Richard Ian
Transaction: 07/01/2026
BUY
Change
+50,000
Price
$10.62
Filing
07/07/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Griffiths Richard Ian | BUY | +865,112 | $10.53 | 07/06/2026 | 07/07/2026 |
| Griffiths Richard Ian | BUY | +50,082 | $10.47 | 07/02/2026 | 07/07/2026 |
| Griffiths Richard Ian | BUY | +50,000 | $10.62 | 07/01/2026 | 07/07/2026 |
| Griffiths Richard Ian | BUY | +169,928 | $10.76 | 06/30/2026 | 07/07/2026 |
| Griffiths Richard Ian | BUY | +330,072 | $10.69 | 06/29/2026 | 07/07/2026 |
| Griffiths Richard Ian | BUY | +2,000 | $7.75 | 10/27/2025 | 02/13/2026 |
| Griffiths Richard Ian | BUY | +20,000 | $5.45 | 08/03/2025 | 02/13/2026 |
| Lemus David | BUY | +90,000 | $2.05 | 01/02/2026 | 01/06/2026 |
| HELLUMS RHONDA LYNETTE | BUY | +375,000 | $2.05 | 01/02/2026 | 01/06/2026 |
| Romano Steven J. | BUY | +300,000 | $2.05 | 01/02/2026 | 01/06/2026 |
| MCINERNEY TIMOTHY | BUY | +90,000 | $2.05 | 01/02/2026 | 01/06/2026 |
| Ede-Golightly James | BUY | +90,000 | $2.05 | 01/02/2026 | 01/06/2026 |
| Ede-Golightly James | BUY | +90,000 | $2.15 | 12/22/2025 | 12/22/2025 |
| Ross Iain | BUY | +900,000 | $2.08 | 12/18/2025 | 12/22/2025 |
| Ede-Golightly James | OTHER | +48,000 | $7.87 | 12/14/2025 | 12/22/2025 |
| Ede-Golightly James | OTHER | 0 | Not reported | 12/14/2025 | 12/22/2025 |
| Griffiths Richard Ian | BUY | +4,034 | $6.14 | 08/01/2025 | 08/04/2025 |
| Griffiths Richard Ian | BUY | +14,342 | $6.18 | 07/31/2025 | 08/04/2025 |
| Griffiths Richard Ian | BUY | +8,923 | $6.14 | 07/30/2025 | 07/31/2025 |
| Griffiths Richard Ian | BUY | +14,559 | $6.20 | 07/29/2025 | 07/31/2025 |